Loren Data's SAM Daily™

fbodaily.com
Home Today's SAM Search Archives Numbered Notes CBD Archives Subscribe
SAMDAILY.US - ISSUE OF AUGUST 24, 2023 SAM #7940
SPECIAL NOTICE

A -- NMRC Bone Marrow Program

Notice Date
8/22/2023 11:29:12 AM
 
Notice Type
Special Notice
 
NAICS
541714 — Research and Development in Biotechnology (except Nanobiotechnology)
 
Contracting Office
NAVAL MEDICAL RESEARCH CENTER SILVER SPRING MD 20910-7500 USA
 
ZIP Code
20910-7500
 
Solicitation Number
1301090869
 
Response Due
9/5/2023 7:00:00 AM
 
Archive Date
09/20/2023
 
Point of Contact
Shamai M. Carter, Phone: 301-319-7673, Deborah M. Sharpe, Phone: 3013196471
 
E-Mail Address
shamai.m.carter.civ@health.mil, deborah.m.sharpe2.civ@health.mil
(shamai.m.carter.civ@health.mil, deborah.m.sharpe2.civ@health.mil)
 
Description
The United States Department Of Naval Medical Research Command (NMRC) intends to award a sole source contract, CareDX Lab Solutions., West Chester, PA. 19382. This notice is not a request for competitive proposals however If interested Government shall consider all responses.� The mission of the DoD Bone Marrow Program is to provide treatment for Armed Forces personnel after exposure to radiation and chemical weapons and to conduct research to improve management of radiation injuries.�When prescribed 90% of drugs work only in 30-50% this is because 90% of individuals are likely to have different clinically actionable pharmacogenetic genotype. There is a strong and well documented correlation between drug efficacy and variation in genes responsible for drug metabolism or transport (Pharmacogenetics; PGx). Design and development of NGS-based assay for detection of pharmacogenetic variants involved in modulating response to Tacrolimus, Cyclophosphamide, Mycophenolate mofetil and Methotrexate, with feasibility studies completed by end of FY24. The assay utilizes hybrid capture technology, which provides better performance across various sample types and lower dropout rates, compared to other enrichment methods, e.g., PCR-based. The assay will be complemented by companion software for data interpretation.� Period Of Performance Sep 6 2023 - Feb 5 2024/ QTY/-5mos. See attached J&A for Specifics. Email your Quote to the following: max.grogl1.civ@health.mil deborah.m.sharpe2.civ@health.mil shamai.m.carter.civ@health.mil
 
Web Link
SAM.gov Permalink
(https://sam.gov/opp/41646af370c24d1891a153e97c83f35a/view)
 
Place of Performance
Address: Silver Spring, MD 20910, USA
Zip Code: 20910
Country: USA
 
Record
SN06800891-F 20230824/230822230052 (samdaily.us)
 
Source
SAM.gov Link to This Notice
(may not be valid after Archive Date)

FSG Index  |  This Issue's Index  |  Today's SAM Daily Index Page |
ECGrid: EDI VAN Interconnect ECGridOS: EDI Web Services Interconnect API Government Data Publications CBDDisk Subscribers
 Privacy Policy  Jenny in Wanderland!  © 1994-2024, Loren Data Corp.